Sign in
4

Changes in Ownership

Natera, Inc. Filed Acc 0001415889-25-022148

PRESIDENT, CLINICALDIAGNOSTICS sold 875 shares at an average $155.46 ($136,027)

  • PRESIDENT, CLINICALDIAGNOSTICS acquired 1,675 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-12 Grant or award : show line 1 in the form 10b5-1 +1,675 124,734 D
2025-08-14 Sale : show line 2 in the form 10b5-1 −867 $155.46 $134,784 123,867 D
2025-08-14 Sale : show line 3 in the form 10b5-1 −8 $155.42 $1,243 123,859 D
Open-market sales · 875 sh · avg $155.46 · $136,027
Loading xslF345X05/form4-08152025_090803.xml…